On February 2, 2021, Flosonics Medical announced the close of a US$14 million funding round led by Arboretum Ventures and including participation from existing investors iGan Partners and Genesys Capital. 

Flosonics Medical is a Canadian medical device company focused on non-invasive hemodynamic monitoring, headquartered in Sudbury, Ontario. Arboretum Ventures is a venture capital firm, headquartered in Ann Arbor, Michigan, specializing in the healthcare sector. 

Gowling WLG advised Flosonics Medical with respect to this investment with a team that included Todd Bissett, Andrew Griffin and Marco Wai.